Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 12, 2012, Pages 4429-4438

  Finkielstain, Gabriela P ^a,c   Kim, Mimi S ^b,d   Sinaii, Ninet ^b   Nishitani, Miki ^b   Van Ryzin, Carol ^b   Hill, Suvimol C ^b   Reynolds, James C ^b   Hanna, Reem M ^b   Merke, Deborah P ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; PREDNISONE; VITAMIN D;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY HEIGHT; BONE DENSITY; BONE MINERAL; CARDIOVASCULAR RISK; CHILD; COHORT ANALYSIS; CONGENITAL ADRENAL HYPERPLASIA; CROSS-SECTIONAL STUDY; ENDOCRINE FUNCTION TEST; FEMALE; HIRSUTISM; HUMAN; HYPERTENSION; INFANT; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; OUTCOME ASSESSMENT; PEDIATRICS; PHENOTYPE; PLASMA RENIN ACTIVITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; TESTICULAR ADRENAL TEST; VITAMIN D DEFICIENCY;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT; MALE; MIDDLE AGED; PROGNOSIS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84870752409     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2102     Document Type: Article

References (42)

1. Merke DP, Bornstein SR 2005 Congenital adrenal hyperplasia. Lancet 365:2125-2136 (Pubitemid 40826971)
2. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, MontoriVM,Oberfield SE, Ritzen M, White PC 2010 Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 95:4133-4160
3. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI 1985 High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 37:650-667 (Pubitemid 16249426)
4. Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S, Han TS, Carroll PV, Conway GS, Rees DA, Stimson RH, Walker BR, Connell JM, Ross RJ 2010 Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 95:5110-5121
5. Finkielstain GP, Chen W, Mehta SP, Fujimura FK, Hanna RM, Van Ryzin C, McDonnell NB, Merke DP 2011 Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 96:E161-E172
6. 2009-2010 National Health and Nutrition Examination Survey. Centers for Disease Control and Prevention: National Center for Health Statistics. http://www.cdc.gov/nchs/data/factsheets/fact-sheet-obesity.pdf
7. Muthusamy K, Elamin MB, Smushkin G, Murad MH, Lampropulos JF, Elamin KB, Abu Elnour NO, Gallegos-Orozco JF, Fatourechi MM, Agrwal N, Lane MA, Albuquerque FN, Erwin PJ, Montori VM 2010 Clinical review: adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. J Clin Endocrinol Metab 95:4161-4172
8. Falkner B 2005 The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Bethesda, MD: National Heart Lung and Blood Institute; 1-48
9. Chobanian A 2004 The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, MD: National Heart Lung and Blood Institute; 1-86
10. Hindmarsh PC 2009 Management of the child with congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 23:193-208
11. Rivkees SA, Crawford JD 2000 Dexamethasone treatment of virilizing congenital adrenal hyperplasia: The ability to achieve normal growth. Pediatrics 106:767-773
12. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470 (Pubitemid 29418240)
13. Rodden AM, Diaz VA, Mainous 3rd AG, Koopman RJ, Geesey ME 2007 Insulin resistance in adolescents. J Pediatr 151:275-279 (Pubitemid 47284128)
14. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM 2011 Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 96:1911-1930
15. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S 2004 Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362-2374 (Pubitemid 38702847)
16. Hickman TB, Briefel RR, Carroll MD, Rifkind BM, Cleeman JI, Maurer KR, Johnson CL 1998 Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med 27:879-890 (Pubitemid 29010857)
17. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith Jr SC, Spertus JA, Costa F 2005 Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752 (Pubitemid 41532612)
18. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy 2001 Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785-795
19. 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1-129
20. Verma S, Green-Golan L, VanRyzin C, Drinkard B, Mehta SP, Weise M, Eisenhofer G, Merke DP 2010 Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasia. Horm Metab Res 42:607-612
21. 2002 Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab 87: 4048-4053
22. Grigorescu-Sido A, Bettendorf M, Schulze E, Duncea I, Heinrich U 2003 Growth analysis in patients with 21-hydroxylase deficiency influence of glucocorticoid dosage, age at diagnosis, phenotype and genotype on growth and height outcome. Horm Res 60:84-90 (Pubitemid 36928675)
23. Kim MS, Merke DP 2009 Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Semin Reprod Med 27:316-321
24. Cornean RE, Hindmarsh PC, Brook CG 1998 Obesity in 21-hydroxylase deficient patients. Arch Dis Child 78:261-263 (Pubitemid 28176340)
25. Völkl TM, Simm D, Beier C, Dörr HG 2006 Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 117:e98-e105 (Pubitemid 46050506)
26. Roche EF, Charmandari E, Dattani MT, Hindmarsh PC 2003 Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report. Clin Endocrinol (Oxf) 58:589-596 (Pubitemid 36566800)
27. Völkl TM, Simm D, Dötsch J, Rascher W, Dörr HG 2006 Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 91:4888-4895 (Pubitemid 44917323)
28. Ostchega Y, Carroll M, Prineas RJ, McDowell MA, Louis T, Tilert T 2009 Trends of elevated blood pressure among children and adolescents: data from the National Health and Nutrition Examination Survey1988-2006. Am J Hypertens 22:59-67
29. Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjöld A, Hagenfeldt K, Thorén M 2007 Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 92:110-116 (Pubitemid 46067517)
30. Williams RM, Deeb A, Ong KK, Bich W, Murgatroyd PR, Hughes IA, Acerini CL 2010 Insulin sensitivity and body composition in children with classical and nonclassical congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 72:155-160
31. Saygili F, Oge A, Yilmaz C 2005 Hyperinsulinemia and insulin insensitivity in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia. Horm Res 63:270-274 (Pubitemid 41159839)
32. Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP 2002 Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab 87:2114-2120 (Pubitemid 34521497)
33. Bachelot A, Chakhtoura Z, Samara-Boustani D, Dulon J, Touraine P, Polak M 2010 Bone health should be an important concern in the care of patients affected by 21 hydroxylase deficiency. Int J Pediatr Endocrinol pii:326275
34. Elnecave RH, Kopacek C, Rigatto M, Keller Brenner J, Sisson de Castro JA 2008 Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency. J Pediatr Endocrinol Metab 21:1155-1162
35. King JA, Wisniewski AB, Bankowski BJ, Carson KA, Zacur HA, Migeon CJ 2006 Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 91:865-869 (Pubitemid 43357751)
36. Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT 2011 Vitamin D status: United States, 2001-2006. NCHS Data Brief 59:1-8
37. Gastaud F, Bouvattier C, Duranteau L, Brauner R, Thibaud E, Kutten F, Bougnères P 2007 Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 92:1391-1396 (Pubitemid 46556415)
38. Jääskeläinen J, Hippeläinen M, Kiekara O, Voutilainen R 2000 Child rate, pregnancy outcome and ovarian function in females with classical 21-hydroxylase deficiency. Acta Obstet Gynecol Scand 79: 687-692 (Pubitemid 30487555)
39. Claahsen-van der Grinten HL, Hermus AR, Otten BJ 2009 Testicular adrenal rest tumours in congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2009:624823
40. Claahsen-van der Grinten HL, Otten BJ, Stikkelbroeck MM, Sweep FC, Hermus AR 2009 Testicular adrenal rest tumours in congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 23:209-220
41. Stikkelbroeck NM, Otten BJ, Pasic A, Jager GJ, Sweep CG, Noordam K, Hermus AR 2001 High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab 86:5721-5728 (Pubitemid 33152615)
42. Claahsen-van der Grinten HL, Sweep FC, Blickman JG, Hermus AR, Otten BJ 2007 Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol 157:339-344 (Pubitemid 47603539)